Haapanen Aleksi, Ramadan Usama Abo, Autti Taina, Joensuu Raimo, Tyynelä Jaana
Institute of Biomedicine/Biochemistry and Neuroscience Research Program, University of Helsinki, P.O. Box 63, FIN-00014 Helsinki, Finland.
Magn Reson Imaging. 2007 Sep;25(7):1024-31. doi: 10.1016/j.mri.2007.03.012. Epub 2007 Apr 23.
Cathepsin D (CTSD; EC 3.4.23.5) is essential for normal development and/or maintenance of neurons in the central nervous system: its deficiency causes a devastating neurological disorder with severely shortened life span in man, sheep and mouse. Neuropathologically, the CTSD deficiencies are characterized by selective neuronal degeneration, gliosis and accumulation of autofluorescent proteinaceous storage material in neurons. Our aim was to study the dynamics behind the pathological alterations occurring in the brains of CTSD-deficient (CTSD-/-) mice by using in vivo magnetic resonance imaging (MRI) and histology. In order to do this, we measured T(2) signal intensity (SI), apparent diffusion coefficient, area and volume of multiple brain structures from MR images acquired using T(2)-, T(1)- and diffusion-weighted sequences at three time points during disease progression. MRI revealed no differences in the brains between CTSD-/- and control mice at postnatal day 15+/-1 (P15+/-1), representing an initial stage of the disease. In the intermediate stage of the disease, P19(+/-1), SI alterations in the thalami of the affected mice became evident in both T(1)- and T(2)-weighted images. The terminal stage of the disease, P25, was characterized by marked alterations in the T(2) SI, apparent diffusion coefficient and volume of multiple brain structures in CTSD-/- mice. In addition, manganese enhanced high-resolution T(1)-weighted 3D sequences (MEMRI) and histological stainings revealed that the hyperintense signal areas in MEMRI matched perfectly with areas of microglial activation in the brains of CTSD-/- mice at the terminal disease stage. In conclusion, the SI alterations in the thalami of CTSD-/- mice preceded other changes, and the degenerative process was greatly enhanced at the age P19(+/-1), leading to severely reduced brain volume in just 6 days.
组织蛋白酶D(CTSD;EC 3.4.23.5)对于中枢神经系统中神经元的正常发育和/或维持至关重要:其缺乏会导致人类、绵羊和小鼠出现严重的神经系统疾病,寿命大幅缩短。在神经病理学上,CTSD缺乏的特征是选择性神经元变性、胶质细胞增生以及神经元中自荧光蛋白质储存物质的积累。我们的目的是通过体内磁共振成像(MRI)和组织学研究CTSD缺陷(CTSD-/-)小鼠大脑中发生的病理改变背后的动态过程。为了做到这一点,我们在疾病进展的三个时间点,从使用T(2)、T(1)和扩散加权序列获取的MR图像中测量了多个脑结构的T(2)信号强度(SI)、表观扩散系数、面积和体积。MRI显示,在出生后第15±1天(P15±1),CTSD-/-小鼠和对照小鼠的大脑没有差异,这代表疾病的初始阶段。在疾病的中间阶段,即P19(±1),在T(1)加权和T(2)加权图像中,受影响小鼠丘脑的SI改变变得明显。疾病的终末期,即P25,其特征是CTSD-/-小鼠多个脑结构的T(2) SI、表观扩散系数和体积发生明显改变。此外,锰增强高分辨率T(1)加权3D序列(MEMRI)和组织学染色显示,在疾病终末期,MEMRI中的高强度信号区域与CTSD-/-小鼠大脑中微胶质细胞激活区域完美匹配。总之,CTSD-/-小鼠丘脑中的SI改变先于其他变化,并且在P19(±1)时变性过程大大增强,导致在短短6天内脑体积严重减小。